Company intelligence / Profile preview
Guilong Pharmaceutical
Ma'anshan, Anhui, Chinaguilong.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Guilong Pharmaceutical is a leading provider of OTC and TCM-based treatments for throat and upper respiratory conditions in China, with flagship products including Manyanshuning. Its main TCM products are widely approved and commercialized in China for cough and bronchitis, with evidence of continued market leadership and clinical use[2][3][4][5].
- Therapeutic areas
- PulmonologyInfectious Diseases
- Modalities
- Herbal medicine
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Reckitt Benckiser (prior acquisition/investment for Chinese base)[1][3]Trustar Capital (current controlling investor/parent)[4][5]
Beyond the preview
Go deeper on Guilong Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Guilong Pharmaceutical.